The Healthy @Reader's Digest on MSN: Ketamine therapy: A medical doctor explains its use for treatment-resistant depression Yahoo Finance: Alar Breaks Key Barriers in Ketamine Therapy with Positive Phase 1 Results for Long-Acting Injectable ALA-3000 for Treatment-Resistant Depression Alar Breaks Key Barriers in Ketamine Therapy with Positive Phase 1 Results for Long-Acting Injectable ALA-3000 for Treatment-Resistant Depression Treatment-resistant depression affects millions of Americans who have tried multiple antidepressants without finding relief. After cycling through different medications, therapy approaches, and ... Medical Dialogues: GH001 Shows Promise as Rapid-Acting Therapy for Treatment-Resistant Depression: JAMA A Cleveland Clinic psychiatrist explains how ketamine therapy is transforming depression treatment—and why it works when other options fall short.
Markets Insider: AtaiBeckley’s BPL-003 Shows Rapid, Durable Antidepressant Response in Treatment-Resistant Depression Patients on SSRIs; Phase 2a Data Published in CNS Drugs AtaiBeckley’s BPL-003 Shows Rapid, Durable Antidepressant Response in Treatment-Resistant Depression Patients on SSRIs; Phase 2a Data Published in CNS Drugs Morning Overview on MSN: Deep brain stimulation is being tested as an option for treatment-resistant depression Deep brain stimulation is being tested as an option for treatment-resistant depression Worsened blood circulation from autonomic dysfunction may contribute to depressive symptoms, offering a new avenue for treatment-resistant depression. What is Deep Brain Stimulation for depression? Discover how the TRANSCEND trial at UT Southwestern is using "brain pacemakers" to treat treatment-resistant depression by targeting neural communication ...
